临床肝胆病杂志2017，Vol.33Issue(8)：1572-1575,4.DOI:10.3969/j.issn.1001-5256.2017.08.035
慢性HBV感染者免疫耐受期自然转归相关影响因素的研究进展
Research advances in influencing factors for natural prognosis of patients with chronic HBV infection in immune tolerance phase
摘要
Abstract
In the natural history of chronic HBV infection,immune tolerance phase is the early stage of disease progression and plays a decisive role in disease monitoring and treatment.The latest CHB guidelines in China and foreign countries recommend regular follow-up for patients in immune tolerance phase,instead of antiviral therapy.Although patients with chronic HBV infection in immune tolerance phase tend to have a good prognosis,they may also have the risk of progression to end-stage liver diseases such as liver cirrhosis,hepatocellular carcinoma,and liver function decompensation.This article elaborates on the influencing factors for natural prognosis of patients with chronic HBV infection in immune tolerance phase and provides a theoretical basis for clinical judgment of patient's conditions,determination of the most appropriate timing for the initiation of antiviral therapy,and individualized management.关键词
肝炎病毒,乙型/免疫耐受/预后/综述Key words
hepatitis B virus/immune tolerance/prognosis/review分类
医药卫生引用本文复制引用
高红艳,刘娜,李春霞,卢荣增,徐光华..慢性HBV感染者免疫耐受期自然转归相关影响因素的研究进展[J].临床肝胆病杂志,2017,33(8):1572-1575,4.基金项目
延安市惠民计划(2014HM-09) （2014HM-09）
